Charles rudin chief of the thoracic oncology service.
New cancer cell treatment.
Michael wang et al.
Kte x19 car t cell therapy in relapsed or refractory mantle cell lymphoma new england journal of medicine 2020.
Doctors first remove t cells from your blood.
Excitement at new cancer treatment.
Then they change genes in the cells to help them find and destroy.
Small cell lung cancer remains a major unmet medical need.
To treat cancer doctors have employed surgery chemotherapy and radiation therapy for years but adoptive cell transfer is an immunotherapy treatment that has rapidly emerged in recent years.
Lurbinectedin is the first new drug approved for second line treatment since 1996.
Many of us in the oncology community will welcome lurbinectedin as a new standard option for patients with recurrent small cell lung cancer said dr.
By james gallagher health editor bbc news website.